Exploring the US Cell Therapy Market with Georgia Tech MBA Students

NecstGen is a mission-driven CDMO, operating as a non-profit organization to challenge the high costs of CGT therapies. From our cutting-edge facility located in Leiden, The Netherlands, we are able to serve clients all over the world, including US-based companies. Over the past few weeks, we and our partners from The Digital Capability Company (DCC) […]

NecstGen is a mission-driven CDMO, operating as a non-profit organization to challenge the high costs of CGT therapies. From our cutting-edge facility located in Leiden, The Netherlands, we are able to serve clients all over the world, including US-based companies.

Over the past few weeks, we and our partners from The Digital Capability Company (DCC) have been working with a group of students from The Georgia Tech Scheller College of Business MBA program in their consulting assignment. Their objective: to provide us with insights and recommendations on how to approach and enter the US Cell Therapy market; Our role: to support the team with sector-specific insights, such competitive intelligence from a European CDMO perspective.

Last week, we had the pleasure to host the group at our facilities, and it was great to finally meet them in person! Brooke E. Leeder Roenitz, Brandon Douglass, John Parkerson, Eric Terry and Chelsea Wright, thank you very much for the visit. It was great to host you all, we hope that you enjoyed the visit as much as we did!

Kees Mensch, Jasper Donkers and Rick Stijnen, thank you for giving us the chance to participate in this project. All of the discussions have been very insightful, and we look forward to the final recommendations from the team!

The First Stages of CAR T Cell Therapy Development

The First Stages of CAR T Cell Therapy Development

Chimeric Antigen Receptor (CAR) T cell therapy represents a transformative approach in medicine, particularly in oncology. This method offers personalised treatment by harnessing a patient's immune system to target and eliminate (cancer) cells. These novel therapies...

Webinar LV Process for CAR T

Webinar LV Process for CAR T

Shifting from traditional, ad hoc methodologies to a structured, data-based development approach to create a scalable, GMP-ready process.

NecstGen Services

Cell Therapy Development & Manufacturing

Viral Vector Development & Manufacturing

Cleanroom Rental

About Us

NecstGen is a non-profit CDMO and Centre of Excellence for Cell and Gene Therapy located in a purpose-built GMP facility in Leiden, The Netherlands. Dedicated to the field of Cell and Gene Therapies, we provide expertise and capacity.

NecstGen

Team

Partners

History

Facility

Ecosystem